SciELO - Scientific Electronic Library Online

vol.27 número10Tratamiento multidisciplinario actual del cáncer de próstata metastásico índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




Links relacionados


Actas Urológicas Españolas

versión impresa ISSN 0210-4806


VELA NAVARRETE, R. et al. Duloxetine and others tricyclic antidepressants: pharmacodynamic effects on lower urinary tract. Actas Urol Esp [online]. 2003, vol.27, n.10, pp.751-766. ISSN 0210-4806.

INTRODUCTION: During years the pharmacology of the lower urinary tract function has been presided by the protagonism of the autonomic nervous system and its components, simpathetic and parasimpathetic. Recent investigations proved a greater complexity of mictional dynamics, attributing a more important role to the central nervous system (SNC), to the striated sphincter and to the afferent arc, offering a new opportunity to the Tricyclic Antidepressants (T.A.), reason for this general review. MATERIAL AND METHODS: Using as reference the work of the First Consultation on Incontinence (Montecarlo, 1999), the previous and later publications about T.A. have been reviewed, including experimental (isometric and "in vivo" studies) and clinical studies, investigating on pharmacological evidences, mechanism of action, tolerance and other effects of T.A. RESULTS: Only a reduced group of T.A. have been submitted to experimental evaluations and employeed in clinical trials. The recent works on Duloxetine have waked up a special interest by their pharmacological potential. CONCLUSIONS: New knowledge on the peripheral and central control of the continence-miction dynamic offer new pathways for the treatment with T.A., whose effectiveness and tolerance are reviewed.

Palabras clave : Tricyclic Antidepressant; Urinary incontinence; Lower urinary tract; Duloxetine.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons